Initial characterization of the vitamin D binding protein (Gc-Globulin) binding site on the neutrophil plasma membrane: Evidence for a chondroitin sulfate proteoglycan
Sj. Dimartino et Rr. Kew, Initial characterization of the vitamin D binding protein (Gc-Globulin) binding site on the neutrophil plasma membrane: Evidence for a chondroitin sulfate proteoglycan, J IMMUNOL, 163(4), 1999, pp. 2135-2142
The vitamin D binding protein (DBP) is a multifunctional plasma protein tha
t can modulate certain immune and inflammatory responses. The diverse cellu
lar functions of DBP appear to require cell surface binding to mediate thes
e processes. Numerous reports have detected DBP bound to the surface of sev
eral cell types and would support the concept of a cell surface binding sit
e for DBP, However, direct evidence for such a molecule has been lacking an
d essentially nothing is known about its basic biochemical properties. In t
he present study, radioiodinated DBP was used as a probe to characterize bi
ochemically the neutrophil DBP binding site. Radiolabeled DBP binds to and
remains associated with the plasma membrane and is not degraded. Quantitati
on of DBP binding to either intact cells or purified plasma membranes showe
d nonsaturable (linear) binding with positive cooperativity, possibly sugge
sting DBP oligomer formation. Solubilization of cell bound I-125-DBP with v
arious nonionic and zwitterionic detergents demonstrated that DBP binds to
a membrane macromolecule that partitions to the detergent insoluble fractio
n. Moreover, this molecule does not associate with the cytoskeleton. Cross-
linking of radiolabeled DBP bound to plasma membranes increased the amount
of protein that partitioned to the insoluble fraction, and analysis of thes
e complexes by SDS-PAGE revealed that they may be very large since they did
not enter the gel, Finally, treatment of plasma membranes with either prot
eases or chondroitinase ABC completely abrogated membrane binding of DBP, s
uggesting that the protein binds to a chondroitin sulfate proteoglycan.